Clinical Trial Update: Parasympathetic Augmentation Via Respiratory Training for Patients With Systolic Heart Failure [NA]

View source ↗

Summary

The clinical trial evaluating parasympathetic augmentation via respiratory training for heart failure patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Lancaster General Hospital | Conditions: Diastolic Heart Failure | NA | Status: TERMINATED